drugset / Trial / NCT02188277
Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy
RandomizedParallel-groupOpen-labelTreatment
Summary
1. To assess the clinical and neurophysiological efficacy of Xeomin® vs. Botox® in children with spastic equine and equinovarus foot deformation in pediatric cerebral palsy 2. To assess the safety of Xeomin® use as compared to Botox® in this patient population
Timeline
- Start
- 2014-07
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 4 iu/kg | Intramuscular |
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 6 iu/kg | Intramuscular |
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 8 iu/kg | Intramuscular |